COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,138 Articles (21,585 medRxiv, 7,553 bioRxiv)

Most recent first Previous |  Page 1545: Articles 15441-15450  | Next

SARS-CoV-2 infection in households with and without young children: Nationwide cohort study
Husby, A., Corn, G., Krause, T. G.
10.1101/2021.02.28.21250921 — Posted: 2021-03-02 Discussion: Onsite
Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal
Meireles, P., Amaro, J., Costa, J. P., Mendes Lopes, M., Varandas, T., Norton, P., Guimaraes, J. T., Severo, M., Barros, H.
10.1101/2021.02.28.21252628 — Posted: 2021-03-02
Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England
Lopez Bernal, J., Andrews, N., Gower, C., Stowe, J., Robertson, C., Tessier, E., Simmons, R., Cottrell, S., Robertson, R., O'Doherty, M., Brown, K., Cameron, C., Stockton, D., McMenamin, J., Ramsay, M.
10.1101/2021.03.01.21252652 — Posted: 2021-03-02 Discussion: Onsite
Shifting research priorities in maternal and child health in the COVID-19 pandemic era in India: a renewed focus on systems strengthening
Mehta, K., Zodpey, S., Banerjee, P., Pocius, S. L., Dhaliwal, B., DeLuca, A., Bhattacharya, S. D., Hegde, S., Sengupta, P., GUPTA, M., Shet, A.
10.1101/2021.02.28.21252648 — Posted: 2021-03-02
A new accessible adaptable COVID-19 model
Osman, I., Baker, M. G., De Courten, M., Baker, A. D. L., Sidloff, D., El Sayes, W. S., Fraser, E., Cohen, C. R., Alqahtani, A. S.
10.1101/2021.02.28.21252633 — Posted: 2021-03-02
Modelled Optimization of SARS-Cov-2 Vaccine Distribution: an Evaluation of Second Dose Deferral Spacing of 6, 12, and 24 weeks
Jurgens, G., Lackner, K.
10.1101/2021.02.28.21252638 — Posted: 2021-03-02
The prevalence, incidence and risk factors of mental health problems and mental health services use before and 9 months after the COVID-19 outbreak among the general Dutch population. A 3-wave prospective study.
van der Velden, P. G., Marchand, M., Das, M., Muffels, R., Bosmans, M.
10.1101/2021.02.27.21251952 — Posted: 2021-03-02
Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern
Long, S. W., Olsen, R. J., Christensen, P. A., Subedi, S., Olson, R., Davis, J. J., Saavedra, M. O., Yerramilli, P., Pruitt, L., Reppond, K., Shyer, M. N., Cambric, J. E., Finkelstein, I. J., Gollihar, J., Musser, J.
10.1101/2021.02.26.21252227 — Posted: 2021-03-02 Discussion: Onsite
Unmasking the Current Scenario of Indian Biomedical Devices Industry: Ventilators being the Heart of the Discussion
Pramanik, S., Karmakar, S., Mukherjee, S., Dhavale, I., Shrestha, R.
10.1101/2021.02.26.21251720 — Posted: 2021-03-02
Seasonal patterns COVID-19 and Flu Like Illnesses comparable
Hoogeveen, M. J., Hoogeveen, E. K.
10.1101/2021.02.28.21252625 — Posted: 2021-03-02 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).